These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4391303)

  • 61. [Clinical experience with a new compound with vasodynamic and capillaroprotective action in the treatment of venous diseases of the lower limbs].
    Bagliani A; Vittori F
    Minerva Cardioangiol; 1972; 20(7):390-6. PubMed ID: 5050746
    [No Abstract]   [Full Text] [Related]  

  • 62. [Experimental studies on the effectiveness of aescin "Reparil" in Parkinson patients].
    Tzavellas O
    Wien Klin Wochenschr; 1968 Jan; 80(2):30-4. PubMed ID: 5691318
    [No Abstract]   [Full Text] [Related]  

  • 63. [Studies on triethyltin sulfate induced brain edema in rats. 1. Changes of the water content of the brain substances and their therapeutic modification by aescin].
    Zoltán OT; Fekete E; Domonkos H; Földi M
    Arzneimittelforschung; 1969 Mar; 19(3):287-8. PubMed ID: 5818770
    [No Abstract]   [Full Text] [Related]  

  • 64. [Biochemistry of inflammation and edema formation as well as pharmacokinetics of aescin].
    Mussgnug G
    Arzneimittelforschung; 1969 Sep; 19(9):1588-93. PubMed ID: 4899295
    [No Abstract]   [Full Text] [Related]  

  • 65. [Association of proscillaridine A, thioridazine and Cori ester in the treatment of aged cardiopathic patients].
    Pastore F; Candela G; Cotugno S
    G Gerontol; 1971 Jul; 19(7):516-25. PubMed ID: 5168227
    [No Abstract]   [Full Text] [Related]  

  • 66. [Therapy of varicose symptom complex with Rexiluven].
    Gehrels PE
    Ther Ggw; 1970 Aug; 109(8):1163-6, 1168-9. PubMed ID: 5531833
    [No Abstract]   [Full Text] [Related]  

  • 67. [Experimental and clinical testing of an aescin and heparinoid containing gel].
    Mittelstaedt R
    Cosmetologica; 1970 May; 19(5):167-70. PubMed ID: 4099966
    [No Abstract]   [Full Text] [Related]  

  • 68. [Sense and nonsense of antivaricose agents].
    Salfeld K
    Z Haut Geschlechtskr; 1969 Sep; 44(18):713-26. PubMed ID: 5382940
    [No Abstract]   [Full Text] [Related]  

  • 69. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
    Brembach H
    Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
    [No Abstract]   [Full Text] [Related]  

  • 70. [The principles of action and use of phlebotropic agents].
    Kharkevich DA
    Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390
    [No Abstract]   [Full Text] [Related]  

  • 71. [Experience with horse chestnut containing medium in the treatment of varicose leg ulcers].
    Horácek J
    Z Haut Geschlechtskr; 1969 Sep; 44(18):743-6. PubMed ID: 5393605
    [No Abstract]   [Full Text] [Related]  

  • 72. [Contribution to drug therapy of varicose diseases].
    Berson I
    Praxis; 1967 Oct; 56(42):1438-41. PubMed ID: 5633172
    [No Abstract]   [Full Text] [Related]  

  • 73. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 74. [Clinical observations on the use of a combination of proscillaridin and theophylline in the treatment of the senile heart and chronic cor pulmonale].
    Martinetti L; Lai G; Rovera R
    Clin Ter; 1968 Sep; 46(6):517-42. PubMed ID: 5754593
    [No Abstract]   [Full Text] [Related]  

  • 75. [Role of vasoactive substances in the treatment of cardiovascular diseases].
    Heine H; Schmidt H; Faulhaber HD; Anders G
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2090-3. PubMed ID: 4405750
    [No Abstract]   [Full Text] [Related]  

  • 76. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency].
    Gubergrits AIa; Leshchinskiĭ LA
    Sov Med; 1968 Jan; 31(1):23-7. PubMed ID: 5691025
    [No Abstract]   [Full Text] [Related]  

  • 77. [Study of the effects of a vasodilator (Butyl-Sympatol) in topical use on the reepithelization of experimental burns in rats].
    Moragas Redecilla A; Rodríguez Casquero C
    Rev Clin Esp; 1966 Feb; 100(4):276-80. PubMed ID: 4379564
    [No Abstract]   [Full Text] [Related]  

  • 78. [Studies on pharmacodynamics and pharmacokinetics of aescin as demonstrated in brain edema].
    Ascher PW
    Wien Med Wochenschr; 1968 Dec; 118(49):1050-1. PubMed ID: 5752690
    [No Abstract]   [Full Text] [Related]  

  • 79. [Aescin (=Reparil) in cerebral circulation disorders. Clinical and ophthalmodynamographic observations].
    Tzavellas O; Finke J
    Wien Klin Wochenschr; 1970 Oct; 82(41):714-6. PubMed ID: 5529668
    [No Abstract]   [Full Text] [Related]  

  • 80. [Vasodilator agents in peripheral arterial occlusive disease with coronary insufficiency, myocardial infarct and pacemakers. Electrocardiographic studies in intravenous naftidrofuryl-infusion].
    Heidrich H; Wehselau H
    Med Welt; 1974 Jul; 25(26):1161-3. PubMed ID: 4845152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.